Search

Displaying results 4231 - 4240 of 5504 in total
  1. Drug

    Ditiocarb

    go.drugbank.com/drugs/DB02520
    Investigational

    It is the main metabolite of DISULFIRAM.

  2. Drug

    N-acetyl-beta-neuraminic acid

    go.drugbank.com/drugs/DB04265
    Experimental

    (From Dorland, 28th ed, p1518)

  3. Drug

    Tandutinib

    go.drugbank.com/drugs/DB05465
    Investigational

    MLN518 is a novel, oral, small molecule designed to inhibit type III receptor tyrosine kinases, including FLT3, (platelet-derived growth-factor receptor) PDGFR and c-KIT. Tyrosine kinases are enzymes involved in several cellular processe...

  4. Drug

    N-Acetylglucosamine

    go.drugbank.com/drugs/DB00141
    ApprovedInvestigationalNutraceutical

    The N-acetyl derivative of glucosamine.

  5. Drug

    GTI 2040

    go.drugbank.com/drugs/DB05801
    Investigational

    It belongs to the family of drugs called antisense oligonucleotides.

  6. Drug

    Dipraglurant

    go.drugbank.com/drugs/DB12733
    Investigational

    It is a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM).

  7. Drug

    {[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid

    go.drugbank.com/drugs/DB08098
    Experimental

    It targets the protein aldose reductase.

  8. Drug

    CA-074 methyl ester

    go.drugbank.com/drugs/DB07223
    Experimental

    It is converted by cellular esterases to CA-074.[A258234,A258239]

  9. Drug

    Gavorestat

    go.drugbank.com/drugs/DB16707
    Investigational

    Gavorestat is under investigation in clinical trial NCT04902781 (Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic Galactosemia).

    Synonyms: AT-007
  10. Drug

    Disitamab vedotin

    go.drugbank.com/drugs/DB17208
    Investigational

    It is currently being investigated for cancers.[A254721]